Tiffany's Shine Get...
Health Care: Drugs
Medicines (MDCO: NASDAQ)
$21.39 0.08 | 0.38%
05/24/12 - 04:00 PM ET
356.55K / 371.40K
Vol / Avg. Vol:21.43 / 21.31
Open / Prev. Close:20.96 - 21.47
Today's Range:12.33 - 22.82
52 Wk Range:13.41%
Performance YTD:TheStreet Rating:
Portfolios with MDCO
- Portfolio NameUser Type
- UserGFNN Stockdiagnostics 3
- ContributorStocks At New 52-Week Highs...
- ContributorBreakout Stocks Of The Week...
- UserSUPRATRADE Top 10 Small Cap...
- Userdarrylb Portfolio 1
- Usermiamirocksters Portfolio 1
- ContributorBarron's Research Reports 4...
- UserPART 3 JPMorgan 27th Annual...
- UserNurse Nymph looks for Medic...
- UserAugust double bottom time t...
Latest MDCO Headlines from TheStreet
- Medicines (MDCO): Today's Featured Health Care Winner 05.17.12 | 05:05 pm
- The Medicines' CEO Presents At Deutsche Bank Annual Healthcare Conference (Transcript) 05.07.12 | 06:05 pm
- Pfizer Q1 Profit Falls 19 Pct On Generic Lipitor 05.01.12 | 07:05 am
- 7 Stocks at New 52-Week Highs 02.23.12 | 06:02 am
- 2 Stocks Hitting 52-Week Highs: The Medicines Cos., Herbalife 02.22.12 | 03:02 pm
- Medicines Reaches New 52-Week High (MDCO) 02.22.12 | 10:02 am
- Industry Bickers Over How To Catch Fake Drugs 02.16.12 | 05:02 pm
- Drugmakers Singing Same Song: 2012 Will Be Tough 02.02.12 | 04:02 pm
- 2 Execs Out At J&J's Troubled Consumer Business 01.31.12 | 03:01 pm
- Medicines Stock Hits New 52-Week High (MDCO) 01.31.12 | 01:01 pm
Press Releases for MDCO
- AstraZeneca And The Medicines Company Announce Global Collaboration In Acute Ischemic Heart Disease - Business Wire 04.25.12 | 12:04 pm
- Boston Scientific Supports New Clinical Trial To Evaluate Platinum Chromium Coronary Stents In Treating Heart Attack Patients - PR Newswire 03.26.12 | 08:03 am
- Ligand And The Medicines Company Agree To Worldwide License For Proprietary Captisol®-Enabled Intravenous Formulation Of Clopidogrel - Business Wire 06.03.11 | 09:06 am
Partner Headlines for MDCO
- Notable Put Options Activity in The Medicines Company - Benzinga 01.09.12 | 01:01 pm
- Company News for June 10, 2011 - Corporate Summary - Zacks 06.10.11 | 10:06 am
- Neutral on The Medicines Co. - Analyst Blog - Zacks 05.26.11 | 07:05 pm
- Value Ideas: Undervalued Stocks With Conservative Accounting Practices - Seeking Alpha 03.04.11 | 05:03 pm
- 4Q Earnings Beat for The Medicines Co. - Analyst Blog - Zacks 02.18.11 | 03:02 pm
- Zacks Bull and Bear of the Day Highlights: The Medicines, Companhia Paranaense de Energia, or COPEL, McDonald's, Abercrombie & Fitch and ExxonMobil Corporation - Press Releases - Zacks 10.11.10 | 09:10 am
- The Medicines Co. (MDCO) - Bull of the Day - Zacks 10.11.10 | 01:10 am
- Medicines Co. Upped to Outperform - Analyst Blog - Zacks 10.08.10 | 09:10 am
- UPDATE 2-Medicines' Angiomax gets 1-yr interim patent extension - Reuters 08.06.10 | 01:08 pm
- UPDATE 1-Medicines Co's anti-clot pill faces more generic risk - Reuters 07.09.10 | 06:07 pm
